You are now viewing 1 - 10 of 39 results
January 1, 2001 | Program Result Report
During the 1980s, expenditures on pharmaceuticals nationwide increased by 152 percent. HMOs implemented a number of cost-control mechanisms to slow the rate of growth of pharmaceutical expenditures, and were successful in doing so compared to fee-for-service health plans.
August 19, 2008 | Journal Article
Seeding trials are clinical studies conducted by pharmaceutical companies designed to seem as if they answer a scientific question, but primarily fulfill marketing objectives they have not been described in detail.
January 1, 2007 | Journal Article
Effects of Losing Prescription Drug Coverage.
June 20, 2007 | Journal Article
Drug classes with the most frequent coverage were found to have at least one drug not covered by two-thirds of formularies.
September 10, 2007 | Journal Article
The present article considered cardiovascular patients' adherence to physicians' medication recommendations. Nonadherence was defined as following the suggested medicine regiment 75 percent or less of the time. Study participants were 1,015 outpatie ...
November 13, 2006 | Journal Article
Tamoxifen citrate has been approved for primary reduction of breast cancer risk since 1998, but studies suggest that its use for primary prevention is limited. The authors report on a national survey mailed to 350 primary care physicians regarding p ...
August 1, 2004 | Journal Article
Modest evidence from controlled clinical studies supports the use of antipsychotic medications to treat severe disruptive behaviors, such as autism and Tourette syndrome, in children and adolescents. However, the use of these drugs to treat milder b ...
August 16, 2004 | Program Result Report
From 2000 to 2001, researchers at Boston University School of Public Health examined how the growth of direct-to-consumer advertising of prescription drugs affects the patient-provider relationship.
October 1, 2004 | Journal Article
The current study explored the nature and extent of the relationship between the number of medications older persons take, or medication exposure, and negative medical effects.
November 1, 2003 | Journal Article
Data indicates that tamoxifen was associated with increased risks of developing endometrial cancer, deep venous thrombosis, strokes, pulmonary emboli, and all gastrointestinal cancers.